Search

everythinglearnresearchcommunity

for

Search:↓

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

The drug combination was safe and showed promise in treating advanced tumors.

S100A6 protein is linked to disease progression, especially in cancers.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Recent advances in hair loss treatments show significant progress.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A patient with complete hair loss regrew all her hair using tofacitinib.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The study found that expanded skin regenerates similarly to normal skin, with 77 genes playing a role in the process.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Upadacitinib effectively treated severe hair loss in a child.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

New, effective treatments for alopecia areata require innovative approaches targeting the immune system.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Urinary Se to creatinine ratio, serum Se, and glutathione peroxidase are effective early biomarkers for selenium status in dogs.

Chronic ethanol increases certain brain receptor levels, influenced by steroids and protein changes.

Enzymatic phosphorylation of hair keratin improves the effectiveness of hair products with cationic ingredients.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

New hair loss treatments have evolved from understanding hair biology and patient needs.

Nilotinib can cause skin issues like red bumps and hair loss.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.